企業プロフィール
Endonovo Therapeutics 株価・ニュース・カタリスト
- ティッカー:
- ENDV
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- United States and traded publicly
株価パフォーマンス
0.00 USD (0.00%)
終値
最終更新: 2026年8月17日
—
時価総額
株価変動の要因
As of Aug 17, 2026, ENDV was little changed and closed at $0.0001. No new same-company headline was identified in the current news window.
企業概要
事業概要
Endonovo Therapeutics was a medical technology company focused on bioelectronic or regenerative applications for inflammation and pain. Its story centered on device-based therapy rather than classic pharmaceuticals.
所在地とセクター分類
Endonovo was headquartered in the United States and traded publicly. It sat in medical technology and bioelectronic medicine.
ビジネスモデルの特徴
The company depended on product development, commercialization, and the ability to show clinical utility. Investors historically watched device progress and strategic changes.
バイオ業界での位置付け
Endonovo occupies a historical bioelectronic-device niche. It is outside biotech therapeutics and more closely aligned with device-driven care.
今後のカタリスト
- Endonovo is a legacy / closeout story, so the catalysts are any remaining strategic or asset-resolution update rather than a live product milestone. The market is focused on residual value.
最近のニュース
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。